Clinical Trial Update: Sitagliptin Dose Determination Study [Phase 4]

View source ↗

Summary

A Phase 4 trial from Albert Einstein College of Medicine assessed sitagliptin dose determination in type 1 diabetes and posted results in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Sitagliptin (sitagliptin)

Snippet

Sponsor: Albert Einstein College of Medicine | Conditions: Diabetes Mellitus, Type 1 | Phase 4 | Status: COMPLETED | Results posted: 2018-07-16